{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:50:24Z","timestamp":1790376624007,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.iac.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T18:16:08Z","timestamp":1468088168000},"page":"559-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Eosinophilic Endotype of Asthma"],"prefix":"10.1016","volume":"36","author":[{"given":"Fernando","family":"Aleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Fang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.iac.2016.03.006_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1155\/2011\/430317","article-title":"Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice","volume":"18","author":"D'Silva","year":"2011","journal-title":"Can Respir J"},{"issue":"15","key":"10.1016\/j.iac.2016.03.006_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2016.03.006_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.iac.2016.03.006_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/thx.52.6.498","article-title":"The use of induced sputum to investigate airway inflammation","volume":"52","author":"Pavord","year":"1997","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.iac.2016.03.006_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2006.08.003","article-title":"Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes","volume":"118","author":"Lemiere","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2016.03.006_bib6","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/nri3341-c1","article-title":"Primary lysis of eosinophils as a major mode of activation of eosinophils in human diseased tissues","volume":"13","author":"Persson","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"37 Suppl","key":"10.1016\/j.iac.2016.03.006_bib7","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1183\/09031936.02.00000102","article-title":"Standardised methodology of sputum induction and processing","volume":"20","author":"Djukanovi\u0107","year":"2002","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.iac.2016.03.006_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1183\/09031936.00.16599700","article-title":"Success and safety of sputum induction in the clinical setting","volume":"16","author":"Vlachos-Mayer","year":"2000","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.iac.2016.03.006_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.00201813","article-title":"Importance of concomitant local and systemic eosinophilia in uncontrolled asthma","volume":"44","author":"Schleich","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2016.03.006_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1183\/09031936.95.08040559","article-title":"Some technical factors influencing the induction of sputum for cell analysis","volume":"8","author":"Popov","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2016.03.006_bib11","first-page":"77","article-title":"Induced sputum : selection method","volume":"56","author":"Kelly","year":"2001","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.iac.2016.03.006_bib12","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1183\/09031936.02.00000102","article-title":"Standardized methodology of sputum induction and processing","volume":"37","author":"Djukanovic","year":"2002","journal-title":"Eur Respir J Suppl"},{"issue":"2","key":"10.1016\/j.iac.2016.03.006_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1155\/2013\/602936","article-title":"Update on clinical inflammometry for the management of airway diseases","volume":"20","author":"Nair","year":"2013","journal-title":"Can Respir J"},{"issue":"6","key":"10.1016\/j.iac.2016.03.006_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/rccm.201311-2069OE","article-title":"Theirs but to die and do: primary lysis of eosinophils and free eosinophil granules in asthma","volume":"189","author":"Persson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.iac.2016.03.006_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S2213-2600(15)00419-1","article-title":"Blood or sputum eosinophils to guide asthma therapy?","volume":"3","author":"Mukherjee","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.iac.2016.03.006_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.iac.2016.03.006_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00151829-200504050-00002","article-title":"Biomarkers predicting response to corticosteroid therapy in asthma","volume":"4","author":"Brightling","year":"2005","journal-title":"Treat Respir Med"},{"issue":"13","key":"10.1016\/j.iac.2016.03.006_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.iac.2016.03.006_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Reslizumab for poorly controlled, eosinophilic asthma","volume":"184","author":"Castro","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.iac.2016.03.006_bib20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab, an anti-interleukin 5 receptor \u03b1 monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.iac.2016.03.006_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.iac.2016.03.006_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.iac.2016.03.006_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","article-title":"Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia","volume":"137","author":"Smith","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2016.03.006_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2013.03.044","article-title":"Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects","volume":"132","author":"Hastie","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.03.006_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thx.2010.135574","article-title":"A\u00a0systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)","volume":"67","author":"Petsky","year":"2012","journal-title":"Thorax"},{"issue":"32","key":"10.1016\/j.iac.2016.03.006_bib26","doi-asserted-by":"crossref","first-page":"14170","DOI":"10.1073\/pnas.1009426107","article-title":"Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma","volume":"107","author":"Sidhu","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"40","key":"10.1016\/j.iac.2016.03.006_bib27","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.iac.2016.03.006_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","article-title":"Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients","volume":"130","author":"Jia","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2016.03.006_bib29","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/cea.12147","article-title":"Predicting steroid responsiveness in patients with asthma using exhaled breath profiling","volume":"43","author":"van der Schee","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.iac.2016.03.006_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpeds.2011.01.029","article-title":"Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children","volume":"159","author":"Wedes","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.iac.2016.03.006_bib31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2013.12.1091","article-title":"Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes","volume":"133","author":"Baines","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"9537","key":"10.1016\/j.iac.2016.03.006_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: defining of the persistent adult phenotypes","volume":"368","author":"Wenzel","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.iac.2016.03.006_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2007.02.042","article-title":"Noneosinophilic asthma: a distinct clinical and pathologic phenotype","volume":"119","author":"Haldar","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.03.006_bib34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2009.06.029","article-title":"Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study","volume":"124","author":"van Veen","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2016.03.006_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1164\/rccm.201301-0156OC","article-title":"Ten-year follow-up of cluster-based asthma phenotypes in adults. A pooled analysis of three cohorts","volume":"188","author":"Boudier","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.iac.2016.03.006_bib36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/all.12445","article-title":"Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma","volume":"69","author":"Kupczyk","year":"2014","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.iac.2016.03.006_bib37","doi-asserted-by":"crossref","first-page":"e102987","DOI":"10.1371\/journal.pone.0102987","article-title":"Statistical cluster analysis of the British Thoracic Society severe refractory asthma registry: clinical outcomes and phenotype stability","volume":"9","author":"Newby","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.iac.2016.03.006_bib38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/thx.2009.126722","article-title":"Effects of steroid therapy on inflammatory cell subtypes in asthma","volume":"65","author":"Cowan","year":"2010","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.iac.2016.03.006_bib39","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.rmed.2007.05.010","article-title":"Changing pattern of sputum cell counts during successive exacerbations of airway disease","volume":"101","author":"D'Silva","year":"2007","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.iac.2016.03.006_bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/rccm.201109-1640OC","article-title":"A\u00a0large subgroup of mild-to-moderate asthma is persistently noneosinophilic","volume":"185","author":"McGrath","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.iac.2016.03.006_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MCP.0000000000000120","article-title":"Therapeutic implications of 'neutrophilic asthma'","volume":"21","author":"Nair","year":"2015","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"10.1016\/j.iac.2016.03.006_bib42","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/ajrccm.164.5.2011026","article-title":"Factors associated with persistent airflow limitation in severe asthma","volume":"164","author":"ten Brinke","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.iac.2016.03.006_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.it.2004.07.006","article-title":"A\u00a0role for eosinophils in airway remodelling in asthma","volume":"25","author":"Kay","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.iac.2016.03.006_bib44","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.iac.2016.03.006_bib45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nrd3792","article-title":"The potential of biologics for the treatment of asthma","volume":"11","author":"Pelaia","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"301","key":"10.1016\/j.iac.2016.03.006_bib46","doi-asserted-by":"crossref","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","article-title":"TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma","volume":"7","author":"Choy","year":"2015","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.iac.2016.03.006_bib47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1968","article-title":"A\u00a0role for natural killer T\u00a0cells in asthma","volume":"6","author":"Umetsu","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.iac.2016.03.006_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaci.2015.01.014","article-title":"Innate and adaptive T\u00a0cells in asthmatic patients: relationship to severity and disease mechanisms","volume":"136","author":"Hinks","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.03.006_bib49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1155\/1999\/434901","article-title":"Non-asthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia","volume":"6","author":"Pizzichini","year":"1999","journal-title":"Can Respir J"},{"issue":"4","key":"10.1016\/j.iac.2016.03.006_bib50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2004.12.1129","article-title":"Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids","volume":"115","author":"Deykin","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.03.006_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1183\/09031936.06.00137704","article-title":"Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations","volume":"27","author":"Jayaram","year":"2006","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.iac.2016.03.006_bib52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N\u00a0Engl J Med"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T05:12:23Z","timestamp":1692421943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856116300066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0889856116300066"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2016.03.006","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilic Endotype of Asthma","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}